nandrolone has been researched along with Experimental Mammary Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, T; Endo, K; Hirai, T; Iino, Y; Ishikawa, H; Izuo, M; Kawai, T; Ogawa, T; Takikawa, H; Yamazaki, K | 1 |
| Boer, GJ; de Bruin, K; Janssen, AG; Rijks, LJ; van den Bos, JC; van Doremalen, PA; van Royen, EA | 1 |
| Bouveng, R; Ellman, M; Gunnarsson, PO; Jensen, G; Liljekvist, J; Müntzing, J | 1 |
| Hung, SC; Liang, T; Liao, S; Tymoczko, JL | 1 |
| Ezumi, K; Horibe, I; Matsumoto, K; Nishizawa, Y; Suzuki, T; Takeda, K; Tanaka, A; Uchida, K; Uchida, N | 1 |
| Elger, W; Grill, HJ; Heubner, A; Hofmeister, H; Laurent, H; Manz, B; Pollow, K; Schulze, PE; Wiechert, R | 1 |
1 review(s) available for nandrolone and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Active forms and biodynamics of the androgen-receptor in various target tissues.
Topics: Aging; Androstanes; Androstenes; Animals; Brain; Castration; Cell Nucleus; Chemical Phenomena; Chemistry; Cytoplasm; Dihydrotestosterone; Female; Feminization; Genes; Liver; Male; Mammary Neoplasms, Experimental; Mice; Muscles; Nandrolone; Organ Specificity; Prostate; Rats; Receptors, Androgen; Receptors, Steroid; Structure-Activity Relationship; Testis; Testosterone | 1976 |
5 other study(ies) available for nandrolone and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
[Effect of medroxyprogesterone acetate (MAP) and vitamin C on DMBA induced rat mammary cancer in relation to estrogen receptor(ER)].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Ascorbic Acid; Female; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Nandrolone; Rats; Rats, Inbred Strains; Receptors, Estrogen | 1983 |
New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Female; Humans; Iodine Radioisotopes; Ligands; Mammary Neoplasms, Experimental; Nandrolone; Ovary; Progesterone Congeners; Rabbits; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Uterus | 1998 |
Effects of LS 1727, a nitrosocarbamate of 19-nortestosterone, on dimethylbenz (a)anthracene-induced mammary tumors in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Dose-Response Relationship, Drug; Female; Hormones; Lomustine; Mammary Neoplasms, Experimental; Nandrolone; Rats; Tissue Distribution | 1979 |
Effects of antiandrogens on growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115) in vivo and in vitro.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Aniline Compounds; Animals; Cell Division; Male; Mammary Neoplasms, Experimental; Mice; Nandrolone; Receptors, Androgen; Steroids; Tumor Cells, Cultured | 1990 |
(Z)-17 beta-hydroxy-17 alpha-(2-[125I]iodovinyl)-4-estren-3-one: a new specific gamma-emitting ligand for determination of progesterone receptor.
Topics: Animals; Cytosol; Female; Humans; In Vitro Techniques; Male; Mammary Neoplasms, Experimental; Nandrolone; Prostate; Radioligand Assay; Rats; Receptors, Androgen; Receptors, Progesterone; Uterus | 1987 |